EUVIMEDEUVIMED entdecken
Crossref

Toll-Like Receptor 4-Dependent Platelet-Related Thrombosis in SARS-CoV-2 Infection

Roberto Carnevale iD, Vittoria Cammisotto, Simona Bartimoccia iD, Cristina Nocella, Valentina Castellani, Marianna Bufano iD, Lorenzo Loffredo iD, Sebastiano Sciarretta iD, Giacomo Frati iD, Antonio Coluccia, Romano Silvestri, Giancarlo Ceccarelli iD und 9 weitere

Circulation Research · 03.02.2023 · 132 (3) · 290-305

DOI: 10.1161/circresaha.122.321541 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Circulation Research, erschienen am 03.02.2023. Verfasst von Roberto Carnevale und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Latina, Italy (R.C., S.S., G.F., M.L.). Hauptthemen laut MEDLINE: COVID-19, Thrombosis. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 68 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

SARS-CoV-2 is associated with an increased risk of venous and arterial thrombosis, but the underlying mechanism is still unclear.

Methods

We performed a cross-sectional analysis of platelet function in 25 SARS-CoV-2 and 10 healthy subjects by measuring Nox2 (NADPH oxidase 2)-derived oxidative stress and thromboxane B 2 , and investigated if administration of monoclonal antibodies against the S protein (Spike protein) of SARS-CoV-2 affects platelet activation. Furthermore, we investigated in vitro if the S protein of SARS-CoV-2 or plasma from SARS-CoV-2 enhanced platelet activation.

Results

Ex vivo studies showed enhanced platelet Nox2-derived oxidative stress and thromboxane B 2 biosynthesis and under laminar flow platelet-dependent thrombus growth in SARS-CoV-2 compared with controls; both effects were lowered by Nox2 and TLR4 (Toll-like receptor 4) inhibitors. Two hours after administration of monoclonal antibodies, a significant inhibition of platelet activation was observed in patients with SARS-CoV-2 compared with untreated ones. In vitro study showed that S protein per se did not elicit platelet activation but amplified the platelet response to subthreshold concentrations of agonists and functionally interacted with platelet TLR4. A docking simulation analysis suggested that TLR4 binds to S protein via three receptor-binding domains; furthermore, immunoprecipitation and immunofluorescence showed S protein-TLR4 colocalization in platelets from SARS-CoV-2. Plasma from patients with SARS-CoV-2 enhanced platelet activation and Nox2-related oxidative stress, an effect blunted by TNF (tumor necrosis factor) α inhibitor; this effect was recapitulated by an in vitro study documenting that TNFα alone promoted platelet activation and amplified the platelet response to S protein via p47phox (phagocyte oxidase) upregulation.

Conclusions

The study identifies 2 TLR4-dependent and independent pathways promoting platelet-dependent thrombus growth and suggests inhibition of TLR4. or p47phox as a tool to counteract thrombosis in SARS-CoV-2.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19ThrombosisHumansAntibodies, MonoclonalBlood PlateletsCross-Sectional StudiesSARS-CoV-2ThromboxanesToll-Like Receptor 4

Stichwörter der Autor:innen

SARS-CoV-2oxidative stresspandemicsplatelet activationthrombosisthromboxane B2toll-like receptors

Substanzen

Antibodies, MonoclonalThromboxanesToll-Like Receptor 4TLR4 protein, human

Autor:innen und Institutionen

  • Department of Medical-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Latina, Italy (R.C., S.S., G.F., M.L.).
  • IRCCS Neuromed, Località Camerelle, Pozzilli (IS), Italy (R.C., S.S., G.F.).
  • Department of Clinical Internal, Anaesthesiological and Cardiovascular Sciences (V. Cammisotto, S.B., C.N., L.L., P.P.), Sapienza University of Rome, Italy.
  • Department of General Surgery and Surgical Speciality (V. Castellani, F.P.), Sapienza University of Rome, Italy.
  • Laboratory affiliated with the Institute Pasteur Italy - Cenci Bolognetti Foundation, Department of Drug Chemistry and Technologies (M.B., A.C., R.S.), Sapienza University of Rome, Italy.
  • Department of Public Health and Infectious Diseases (G.C., A.O., M.V., C.M.M.), Sapienza University of Rome, Italy.

ORCID-Profile: Roberto Carnevale, Simona Bartimoccia, Marianna Bufano, Lorenzo Loffredo, Sebastiano Sciarretta, Giacomo Frati, Giancarlo Ceccarelli, Alessandra Oliva, Ombretta Turriziani, Martina Leopizzi, Pasquale Pignatelli, Francesco Violi

Zitieren

APA

Carnevale, R., Cammisotto, V., Bartimoccia, S., Nocella, C., Castellani, V., Bufano, M., Loffredo, L., Sciarretta, S., Frati, G., Coluccia, A., Silvestri, R., Ceccarelli, G., Oliva, A., Venditti, M., Pugliese, F., Maria Mastroianni, C., Turriziani, O., Leopizzi, M., D'Amati, G., …, & Violi, F. (2023). Toll-Like Receptor 4-Dependent Platelet-Related Thrombosis in SARS-CoV-2 Infection. Circulation Research, 132(3), 290-305. https://doi.org/10.1161/circresaha.122.321541

Vancouver

Carnevale R, Cammisotto V, Bartimoccia S, Nocella C, Castellani V, Bufano M, et al. Toll-Like Receptor 4-Dependent Platelet-Related Thrombosis in SARS-CoV-2 Infection. Circulation Research. 2023;132(3):290-305. doi:10.1161/circresaha.122.321541

BibTeX
@article{Carnevale2023,
  author = {Carnevale, Roberto and Cammisotto, Vittoria and Bartimoccia, Simona and Nocella, Cristina and Castellani, Valentina and Bufano, Marianna and Loffredo, Lorenzo and Sciarretta, Sebastiano and Frati, Giacomo and Coluccia, Antonio and Silvestri, Romano and Ceccarelli, Giancarlo and Oliva, Alessandra and Venditti, Mario and Pugliese, Francesco and Maria Mastroianni, Claudio and Turriziani, Ombretta and Leopizzi, Martina and D'Amati, Giulia and Pignatelli, Pasquale and Violi, Francesco},
  title = {Toll-Like Receptor 4-Dependent Platelet-Related Thrombosis in SARS-CoV-2 Infection},
  journal = {Circulation Research},
  year = {2023},
  volume = {132},
  number = {3},
  pages = {290--305},
  doi = {10.1161/circresaha.122.321541}
}
Kostenlos starten →